Bolt Biotherapeutics, Inc. Annual General and Administrative Expense in USD from 2020 to 2023

Taxonomy & unit
us-gaap: USD
Description
The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.
Summary
Bolt Biotherapeutics, Inc. quarterly/annual General and Administrative Expense history and growth rate from 2020 to 2023.
  • Bolt Biotherapeutics, Inc. General and Administrative Expense for the quarter ending September 30, 2024 was $3.8M, a 34% decline year-over-year.
  • Bolt Biotherapeutics, Inc. General and Administrative Expense for the twelve months ending September 30, 2024 was $20M, a 11.3% decline year-over-year.
  • Bolt Biotherapeutics, Inc. annual General and Administrative Expense for 2023 was $22.5M, a 1.73% decline from 2022.
  • Bolt Biotherapeutics, Inc. annual General and Administrative Expense for 2022 was $22.9M, a 24.7% increase from 2021.
  • Bolt Biotherapeutics, Inc. annual General and Administrative Expense for 2021 was $18.4M, a 103% increase from 2020.
General and Administrative Expense, Trailing 12 Months (USD)
General and Administrative Expense, Annual (USD)
General and Administrative Expense, YoY Annual Growth (%)
* An asterisk sign (*) next to the value indicates that the value is likely invalid.